Company Registration No. 07548423 (England and Wales)
CASTLE HEALTHCARE SUPPLIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
CASTLE HEALTHCARE SUPPLIES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
CASTLE HEALTHCARE SUPPLIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,589,236
1,073,150
Investments
5
48,000
48,000
1,637,236
1,121,150
Current assets
Stocks
88,657
161,224
Debtors
7
707,888
721,109
Cash at bank and in hand
228,324
753,169
1,024,869
1,635,502
Creditors: amounts falling due within one year
8
(797,688)
(762,583)
Net current assets
227,181
872,919
Total assets less current liabilities
1,864,417
1,994,069
Creditors: amounts falling due after more than one year
9
(84,569)
(357,222)
Provisions for liabilities
10
(21,928)
(29,238)
Net assets
1,757,920
1,607,609
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
1,757,820
1,607,509
Total equity
1,757,920
1,607,609
CASTLE HEALTHCARE SUPPLIES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -
For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 23 September 2025 and are signed on its behalf by:
R. Hoggart Esq.
Director
Company registration number 07548423 (England and Wales)
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
1
Accounting policies
Company information
Castle Healthcare Supplies Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lancaster House, Lancaster Road, Carnaby, Bridlington, East Yorkshire, YO15 3QY.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings Freehold
Nil
Plant and machinery
25% straight line per annum
Fixtures, fittings & equipment
25% on net book value per annum
Motor vehicles
25% on net book value per annum
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.4
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax is provided in full on all material timing differences that have originated but not reversed at the balance sheet date. A deferred tax asset is regarded as recoverable and therefore recognised only when, on the basis of all available evidence, it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred tax assets and liabilities are not discounted.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
10
11
3
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
76,131
65,172
Adjustments in respect of prior periods
2
Total current tax
76,133
65,172
Deferred tax
Origination and reversal of timing differences
(7,310)
201
Total tax charge
68,823
65,373
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Profit before taxation
275,234
277,843
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
68,809
65,349
Tax effect of expenses that are not deductible in determining taxable profit
14
13
Capital allowances in excess of depreciation
(190)
Deferred tax movement
(7,310)
201
Depreciation in excess of capital allowances
7,310
Taxation charge for the year
68,823
65,373
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery
Total
£
£
£
Cost
At 1 January 2024
956,199
309,928
1,266,127
Additions
545,323
439
545,762
At 31 December 2024
1,501,522
310,367
1,811,889
Depreciation and impairment
At 1 January 2024
192,976
192,976
Depreciation charged in the year
29,677
29,677
At 31 December 2024
222,653
222,653
Carrying amount
At 31 December 2024
1,501,522
87,714
1,589,236
At 31 December 2023
956,199
116,951
1,073,150
5
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
48,000
48,000
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
6
Subsidiaries
Details of the company's subsidiaries at 31 December 2024 are as follows:
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Care Meds (UK) Limited
England
Ordinary
100.00
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Capital and Reserves
Profit/(Loss)
£
£
Care Meds (UK) Limited
153,549
51,810
7
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
35,953
10,109
Amounts due from related undertakings
661,006
700,811
Other debtors and prepayments
10,929
10,189
707,888
721,109
8
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
264,505
22,550
Trade creditors
255,195
378,853
Amounts due to related undertakings
186,685
230,948
Corporation tax
39,632
65,171
Other taxation and social security
4,293
5,257
Other creditors
47,378
59,804
797,688
762,583
9
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
80,735
345,699
Other creditors
3,834
11,523
84,569
357,222
CASTLE HEALTHCARE SUPPLIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
10
Provisions for liabilities
2024
2023
£
£
Deferred tax liabilities
21,928
29,238
11
Controlling party
The company is controlled by R. Hoggart Esq.
2024-12-312024-01-01falsefalsefalse23 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityR. Hoggart Esq.A. Hoggart Esq.D. Hoggart Esq.075484232024-01-012024-12-31075484232024-12-31075484232023-12-3107548423core:LandBuildings2024-12-3107548423core:OtherPropertyPlantEquipment2024-12-3107548423core:LandBuildings2023-12-3107548423core:OtherPropertyPlantEquipment2023-12-3107548423core:ShareCapital2024-12-3107548423core:ShareCapital2023-12-3107548423core:RetainedEarningsAccumulatedLosses2024-12-3107548423core:RetainedEarningsAccumulatedLosses2023-12-3107548423bus:Director12024-01-012024-12-3107548423core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3107548423core:PlantMachinery2024-01-012024-12-3107548423core:FurnitureFittings2024-01-012024-12-3107548423core:MotorVehicles2024-01-012024-12-31075484232023-01-012023-12-3107548423core:UKTax2024-01-012024-12-3107548423core:UKTax2023-01-012023-12-310754842312024-01-012024-12-310754842312023-01-012023-12-310754842322024-01-012024-12-310754842322023-01-012023-12-3107548423core:LandBuildings2023-12-3107548423core:OtherPropertyPlantEquipment2023-12-31075484232023-12-3107548423core:LandBuildings2024-01-012024-12-3107548423core:OtherPropertyPlantEquipment2024-01-012024-12-3107548423core:Subsidiary12024-01-012024-12-3107548423core:Subsidiary112024-01-012024-12-3107548423core:Subsidiary12024-12-3107548423core:CurrentFinancialInstruments2024-12-3107548423core:CurrentFinancialInstruments2023-12-3107548423core:Non-currentFinancialInstruments2024-12-3107548423core:Non-currentFinancialInstruments2023-12-3107548423bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107548423bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107548423bus:FRS1022024-01-012024-12-3107548423bus:AuditExemptWithAccountantsReport2024-01-012024-12-3107548423bus:Director22024-01-012024-12-3107548423bus:Director32024-01-012024-12-3107548423bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP